Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

Abstract EN

Specific immunotherapies, including vaccines with autologous tumor cells and tumor antigen-specific monoclonal antibodies, are important treatments for PC patients.

To evaluate the clinical outcomes of PC-specific immunotherapy, we performed a systematic review and meta-analysis of the relevant published clinical trials.

The effects of specific immunotherapy were compared with those of nonspecific immunotherapy and the meta-analysis was executed with results regarding the overall survival (OS), immune responses data, and serum cancer markers data.

The pooled analysis was performed by using the random-effects model.

We found that significantly improved OS was noted for PC patients utilizing specific immunotherapy and an improved immune response was also observed.

In conclusion, specific immunotherapy was superior in prolonging the survival time and enhancing immunological responses in PC patients.